Keep Defendant in Opioid Trial
March 18, 2020
Source: Law360
Long Island’s Nassau County urged a New York state court not to sever the drugmaker Mallinckrodt from an upcoming opioid trial amid news that the company had struck a tentative $1.6 billion settlement and is close to bankruptcy, with the county saying “anticipated” developments aren’t enough to justify a separate trial.
A lawyer representing the county, Hunter Shkolnik of Napoli Shkolnik PLLC, told Law360 on Tuesday: “Mallinckrodt has been threatening bankruptcy and using it as a sword to extract a settlement.”
Download
Featured Attorneys
Related Articles
Dangers of Mixing Alcohol and Summer Heat
August 13, 2018
Summer time is known for fun in the sun and good times with friends and family. Many people end up celebrating summer with drinks and food and lots of time outdoors. A cold drink on a hot day is as refreshing as it gets, as long as you are picking up the right drink. However,…Read the article
FDA Demands Zantac Recall
April 6, 2020
Recent evidence links the popular heartburn medication to an increased cancer risk, thus FDA demands Zantac recall. The agency wants all ranitidine off store shelves effective immediately. Currently, the Food and Drug Administration is sending letters to Sanofi and other ranitidine manufactures asking them to stop making and shipping product. Additionally, the FDA advises consumers…Read the article